Clinical Trials Logo

Constipation clinical trials

View clinical trials related to Constipation.

Filter by:

NCT ID: NCT04014816 Completed - Constipation Clinical Trials

Gastrointestinal Dysfunction During Enteral Nutrition in Critically Ill Patients

Start date: January 1, 2015
Phase:
Study type: Observational

Gastrointestinal (GI) motility disorders in intensive care patients remain relatively unexplored. Nowadays, the frequency, risk factors and complications of GI dysfunction during enteral nutrition (EN) become more questionable. Our aim is to evaluate the frequency, risk factors and complications of GI dysfunction during EN in the first 2 weeks of the intensive care unit (ICU) stay and to identify precautions to prevent the development of GI dysfunction and avoid complications.

NCT ID: NCT03937739 Completed - Constipation Clinical Trials

Nutrition and Constipation at Inguinal Hernia Patients

Start date: March 1, 2018
Phase:
Study type: Observational

There are lots of inguinal hernia risk factors determined in the literature. But the relationship between nutritional status and inguinal hernia were not examined yet. In this study the investigators evaluated the constipation scale and food consumption of the inguinal hernia patients. This Case-Control study was performed between March 2018- March 2019. The patients who admitted for operation with inguinal hernia were the case group (n:115) and the patients who were admitted to the same hospital without inguinal hernia were control group (n:88). The age, body mass index, alcohol and smoking habits, daily activity, frequency of food consumption and the Wexner constipation scoring were examined using questionnaire were noted.

NCT ID: NCT03885973 Completed - Clinical trials for Constipation - Functional

Lactobacillus Plantarum IS 10560 Supplementation in Women With Functional Constipation

Start date: July 28, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

In this study, the investigators measured the SCFA (Butyrate, Acetate and Propionate) as a Biomarker improvement symptom and quality of life women with functional constipation after supplementation of commensal bacterial fermented milk Lactobacillus plantarum (isolated from indigenous probiotics from Dadih, West Sumatra) for 21 days

NCT ID: NCT03879239 Completed - Clinical trials for Chronic Idiopathic Constipation

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation

Vibrant
Start date: March 30, 2019
Phase: N/A
Study type: Interventional

The study is a prospective, randomized, multicenter, adaptive design, double blinded, placebo-controlled study, to evaluate the efficacy and safety of Vibrant Capsule vs. placebo in relieving constipation in subjects with Chronic Idiopathic Constipation.

NCT ID: NCT03845673 Completed - Constipation Clinical Trials

Fiber Regimens for Constipation Symptoms

constipation
Start date: July 2003
Phase: N/A
Study type: Interventional

The objective of the current study is to compare the effects of bowel recipe with psyllium on symptoms associated with constipation.

NCT ID: NCT03829358 Completed - Clinical trials for Constipation - Functional

The Role of Probiotics in Improving Quality of Life in Women With Functional Constipation

Start date: February 24, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This study aimed to investigate the relationship between administration of probiotics and improvement in quality of life in women with functional constipation.

NCT ID: NCT03821532 Completed - Clinical trials for Constipation - Functional

Adherence/Outcomes After Use of Constipation Action Plan

Start date: September 13, 2016
Phase: N/A
Study type: Interventional

Adherence to recommendations for treatment of chronic constipation in pediatric population is often poor. This study is attempting to improve adherence, and outcomes, by implementing a trial of a constipation action plan plus standard of care, compared to standard of care alone, in an outpatient pediatric population.

NCT ID: NCT03797586 Completed - Clinical trials for Opioid-induced Constipation in Patients With Cancer

Effect of Electroacupuncture on Opioid-induced Constipation in Patients With Cancer

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Approximately 70-80% of patients with advanced disease will be affected by moderate to severe pain. Opioid analgesics represented by morphine and oxycodone are the cornerstone of cancer-pain management, and recommended for use in the management of moderate to severe cancer pain according to WHO Cancer Pain Relief Guidelines. One view is that a trial of systemic opioid therapy should be administered to all cancer patients with pain of moderate or greater severity regardless of the pain mechanism. Although opioids analgesics do work well as relieving pain and improving quality of life via their action at opioid receptors in the central nervous system (CNS) and the peripheral nervous system, they also have powerful adverse effects. The overall occurrence of opioid-related adverse drug events has ranged from1.8% to 13.6%. Opioid-induced constipation (OIC), one of the most prevalent adverse events (AEs) in patients receiving opioid analgesics, defined as a change in baseline bowel habits or defecatory patterns following initiation, alteration, or increase in opioid therapy. The prevalence of OIC has been estimated to affect 41% of patients with chronic noncancer pain taking opioids and 94% of cancer patients taking opioids for pain. Unlike many other opioid-related AEs, OIC is persistent and rarely tolerated. OIC impacts pain control, patients' quality of life and may cause patients to reduce the dose or discontinue opioid use. Acupuncture, a traditional Chinese medicine, has been used to treat gastrointestinal disease including constipation for thousands of years. Two systematic reviews concluded that acupuncture can improve spontaneous bowel movements for functional constipation, and our recent study indicated that electroacupuncture(EA) could increase complete spontaneous bowel movements and is safe for chronic severe functional constipation. Acupuncture could improve gastrointestinal function via facilitating gastrointestinal motility. Currently, there is little detailed information available regarding the acupuncture use for OIC. The objective of this study is to assess the efficacy and safety of EA for OIC in patients with cancer.

NCT ID: NCT03781791 Completed - Parkinson Disease Clinical Trials

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

KARMET
Start date: December 10, 2018
Phase: Phase 2
Study type: Interventional

This study will be conducted as a multi-center, randomized, double-blind, placebo-controlled study. Approximately 72 patients will be randomized 3:1 to treatment or placebo, with approximately 54 patients allocated to receive the active investigational product and approximately 18 patients allocated to receive placebo. - Study Update- Amendment 3 - In this amendment, an additional 80 patients (approximately) will be randomized 1:1 to treatment or placebo (double-blind) with approximately 40 subjects allocated to each group.

NCT ID: NCT03764995 Completed - Constipation Clinical Trials

The Effects of Abdominal Massage on Functional (Primary) Chronic Constipation

Start date: December 10, 2018
Phase: N/A
Study type: Interventional

The aim of the present study is to investigate the efficacy of abdominal massage in patients with functional (primary) chronic constipation. The present study is designed as a randomized placebo controlled. Since the placebo group is included in the research design, if there is a greater improvement of symptoms of constipation and quality of life in the massage group when compared to the control group, it will be determined that this effect is not related to a placebo effect. If the efficacy of Abdominal Massage is revealed with a placebo controlled design, the therapist effect will be eliminated and further evidence on a well-known massage technique in functional (primary) chronic constipation, a common gastrointestinal problem, will be provided. The results of the present placebo controlled randomized trial will indicate that the need for pharmacological agents and the side effects associated with these agents will be reduced. According to the literature, there are studies that investigate the effects of abdominal massage on symptoms of constipation and quality of life. However, it has generally been used for secondary constipation or two applications have been compared. In addition, there is no randomized placebo-controlled study investigating the effect of abdominal massage on severity of chronic constipation and quality of life.